Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07015268
PHASE3

A Clinical Study of KLH-2109 in Patients With Endometriosis

Sponsor: Kissei Pharmaceutical Co., Ltd.

View on ClinicalTrials.gov

Summary

To verify the non-inferiority of KLH-2109 to leuprorelin acetate in a double-blind manner in terms of efficacy in endometriosis patients with pelvic pain.

Official title: Phase III Confirmatory Study of KLH-2109 in Patients With Endometriosis

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

288

Start Date

2025-06-09

Completion Date

2027-11

Last Updated

2026-03-02

Healthy Volunteers

No

Conditions

Interventions

DRUG

KLH-2109

\- KLH-2109 tablet: Oral administration \- Leuprorelin acetate placebo: Subcutaneous administration

DRUG

Leuprorelin acetate

\- KLH-2109 placebo tablet: Oral administration \- Leuprorelin acetate: Subcutaneous administration

Locations (1)

Research Site

Multiple Locations, Japan